{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T18:39:30Z","timestamp":1791916770876,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T00:00:00Z","timestamp":1614902400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010969","name":"Alzheimer Nederland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010969","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organisation for Health Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Aging"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.neurobiolaging.2021.02.024","type":"journal-article","created":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T16:25:01Z","timestamp":1614961501000},"page":"158.e1-158.e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia"],"prefix":"10.1016","volume":"103","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2570-8796","authenticated-orcid":false,"given":"Emma L.","family":"van der Ende","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7591-6051","authenticated-orcid":false,"given":"Estrella","family":"Morenas-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corey","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7447-6218","authenticated-orcid":false,"given":"Murray","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raquel","family":"Sanchez-Valle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rik","family":"Vandenberghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolande A.L.","family":"Pijnenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Laforce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle Le","family":"Ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Lleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Haass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Suarez-Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"van Swieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harro","family":"Seelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0001","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s13195-019-0562-4","article-title":"CSF biomarkers of neuroinflammation in distinct forms and subtypes of neurodegenerative dementia","volume":"12","author":"Abu-Rumeileh","year":"2019","journal-title":"Alzheimers Res Ther"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0002","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13024-016-0132-1","article-title":"Progranulin promotes peripheral nerve regeneration and reinnervation: role of notch signaling","volume":"11","author":"Altmann","year":"2016","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurobiolaging.2021.02.024_bib0003","doi-asserted-by":"crossref","first-page":"8","DOI":"10.3389\/fnagi.2017.00008","article-title":"Increase of TREM2 during aging of an Alzheimer's disease mouse model is paralleled by microglial activation and amyloidosis","volume":"9","author":"Brendel","year":"2017","journal-title":"Front Aging Neurosci"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0004","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1038\/s41582-019-0231-z","article-title":"Neuroinflammation in frontotemporal dementia","volume":"15","author":"Bright","year":"2019","journal-title":"Nat Rev Neurol"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0005","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1080\/146608200300079536","article-title":"El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis","volume":"1","author":"Brooks","year":"2000","journal-title":"Amyotroph Lateral Scler Other Motor Neuron Disord"},{"issue":"12","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0006","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awx198","article-title":"Progranulin: a new avenue towards the understanding and treatment of neurodegenerative disease","volume":"140","author":"Chitramuthu","year":"2017","journal-title":"Brain"},{"issue":"9","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0007","doi-asserted-by":"crossref","first-page":"e12308","DOI":"10.15252\/emmm.202012308","article-title":"Higher CSF sTREM2 and microglia activation are associated with slower rates of beta-amyloid accumulation","volume":"12","author":"Ewers","year":"2020","journal-title":"EMBO Mol Med"},{"issue":"507","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0008","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aav6221","article-title":"Increased soluble TREM2 in cerebrospinal fluid is associated with reduced cognitive and clinical decline in Alzheimer's disease","volume":"11","author":"Ewers","year":"2019","journal-title":"Sci Transl Med"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0009","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s13024-020-00407-2","article-title":"Higher CSF sTREM2 attenuates ApoE4-related risk for cognitive decline and neurodegeneration","volume":"15","author":"Franzmeier","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0010","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1212\/WNL.0b013e31821103e6","article-title":"Classification of primary progressive aphasia and its variants","volume":"76","author":"Gorno-Tempini","year":"2011","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0011","doi-asserted-by":"crossref","first-page":"e9711","DOI":"10.15252\/emmm.201809711","article-title":"Opposite microglial activation stages upon loss of PGRN or TREM2 result in reduced cerebral glucose metabolism","volume":"11","author":"G\u00f6tzl","year":"2019","journal-title":"EMBO Mol Med"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0012","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1093\/brain\/awy079","article-title":"Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer's disease","volume":"141","author":"Hamelin","year":"2018","journal-title":"Brain"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0013","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/nri3705","article-title":"Innate immune activation in neurodegenerative disease","volume":"14","author":"Heneka","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.neurobiolaging.2021.02.024_bib0014","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s13024-016-0071-x","article-title":"Increased cerebrospinal fluid soluble TREM2 concentration in Alzheimer's disease","volume":"11","author":"Heslegrave","year":"2016","journal-title":"Mol Neurodegener"},{"issue":"7","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0015","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","article-title":"A unique microglia type associated with restricting development of Alzheimer's disease","volume":"169","author":"Keren-Shaul","year":"2017","journal-title":"Cell"},{"issue":"13","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0016","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.15252\/embj.201796516","article-title":"The FTD-like syndrome causing TREM2 T66M mutation impairs microglia function, brain perfusion, and glucose metabolism","volume":"36","author":"Kleinberger","year":"2017","journal-title":"Embo J"},{"issue":"243","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0017","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009093","article-title":"TREM2 mutations implicated in neurodegeneration impair cell surface transport and phagocytosis","volume":"6","author":"Kleinberger","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.neurobiolaging.2021.02.024_bib0018","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neulet.2018.08.038","article-title":"Soluble TREM2 changes during the clinical course of Alzheimer's disease: a meta-analysis","volume":"686","author":"Liu","year":"2018","journal-title":"Neurosci Lett"},{"issue":"4","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0019","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.cell.2016.04.001","article-title":"Progranulin deficiency promotes circuit-specific synaptic pruning by microglia via complement activation","volume":"165","author":"Lui","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0020","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13024-020-00374-8","article-title":"Dynamic changes of CSF sTREM2 in preclinical Alzheimer's disease: the CABLE study","volume":"15","author":"Ma","year":"2020","journal-title":"Mol Neurodegener"},{"issue":"11","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0021","doi-asserted-by":"crossref","first-page":"3955","DOI":"10.1172\/JCI63113","article-title":"Progranulin deficiency promotes neuroinflammation and neuron loss following toxin-induced injury","volume":"122","author":"Martens","year":"2012","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0022","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1136\/jnnp-2018-318868","article-title":"Different neuroinflammatory profile in amyotrophic lateral sclerosis and frontotemporal dementia is linked to the clinical phase","volume":"90","author":"Oeckl","year":"2019","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"Pt 11","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0023","doi-asserted-by":"crossref","first-page":"3081","DOI":"10.1093\/brain\/awn217","article-title":"Identification of soluble TREM-2 in the cerebrospinal fluid and its association with multiple sclerosis and CNS inflammation","volume":"131","author":"Piccio","year":"2008","journal-title":"Brain"},{"issue":"6","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0024","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1007\/s00401-016-1533-5","article-title":"Cerebrospinal fluid soluble TREM2 is higher in Alzheimer disease and associated with mutation status","volume":"131","author":"Piccio","year":"2016","journal-title":"Acta Neuropathol"},{"issue":"Pt 9","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0025","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1093\/brain\/awr179","article-title":"Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia","volume":"134","author":"Rascovsky","year":"2011","journal-title":"Brain"},{"issue":"10","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0026","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.15252\/emmm.201707672","article-title":"An Alzheimer-associated TREM2 variant occurs at the ADAM cleavage site and affects shedding and phagocytic function","volume":"9","author":"Schlepckow","year":"2017","journal-title":"EMBO Mol Med"},{"issue":"5","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0027","doi-asserted-by":"crossref","first-page":"466","DOI":"10.15252\/emmm.201506123","article-title":"sTREM2 cerebrospinal fluid levels are a potential biomarker for microglia activity in early-stage Alzheimer's disease and associate with neuronal injury markers","volume":"8","author":"Su\u00e1rez-Calvet","year":"2016","journal-title":"EMBO Mol Med"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0028","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13024-018-0301-5","article-title":"Early increase of CSF sTREM2 in Alzheimer's disease is associated with tau related-neurodegeneration but not with amyloid-\u03b2 pathology","volume":"14","author":"Su\u00e1rez-Calvet","year":"2019","journal-title":"Mol Neurodegener"},{"key":"10.1016\/j.neurobiolaging.2021.02.024_bib0029","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.neuroscience.2012.11.032","article-title":"Exacerbated inflammatory responses related to activated microglia after traumatic brain injury in progranulin-deficient mice","volume":"231","author":"Tanaka","year":"2013","journal-title":"Neuroscience"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000506282","article-title":"Cerebrospinal fluid YKL-40 and chitotriosidase levels in frontotemporal dementia vary by clinical, genetic and pathological subtype","volume":"49","author":"Woollacott","year":"2020","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"1","key":"10.1016\/j.neurobiolaging.2021.02.024_bib0031","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13195-018-0405-8","article-title":"Cerebrospinal fluid soluble TREM2 levels in frontotemporal dementia differ by genetic and pathological subgroup","volume":"10","author":"Woollacott","year":"2018","journal-title":"Alzheimers Res Ther"}],"container-title":["Neurobiology of Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000798?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197458021000798?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:38:13Z","timestamp":1759318693000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197458021000798"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":31,"alternative-id":["S0197458021000798"],"URL":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.024","relation":{},"ISSN":["0197-4580"],"issn-type":[{"value":"0197-4580","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"CSF sTREM2 is elevated in a subset in GRN-related frontotemporal dementia","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Aging","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neurobiolaging.2021.02.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}